Bioventus Inc.
BVS· Nasdaq
Bioventus Inc.
- Last sale
- Oct 2, 2026 · -2.34%
- Market cap
- $1.10B
- 84.09M shares
- Filings
- 460
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $568,087,000 | reported | |
| FY 2024 | 2024-12-31 | $573,280,000 | reported | |
| FY 2023 | 2023-12-31 | $512,345,000 | reported | |
| FY 2022 | 2022-12-31 | $512,117,000 | reported | |
| FY 2021 | 2021-12-31 | $430,898,000 | reported | |
| FY 2020 | 2020-12-31 | $321,161,000 | reported | |
| FY 2019 | 2019-12-31 | $340,141,000 | reported |
Bioventus Inc. · CIK 1665988 · Engraved from SEC EDGAR
